SCHEMBL9315317

SCHEMBL9315317

CC(C)[SiH]Cc1ccccc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TAAR1 Q96RJ0 4/20 0.44
SIGMAR1 Q99720 4/20 0.44
SLC6A2 P23975 3/20 0.44
SLC6A4 P31645 2/20 0.44
SLC6A3 Q01959 2/20 0.44
MAOA P21397 1/20 0.44
CYP2A6 P11509 1/20 0.44
ADORA2A P29274 1/20 0.44
ADORA1 P30542 1/20 0.44
TP53 P04637 1/20 0.42
SLC18A2 Q05940 1/20 0.41
CYP2D6 P10635 1/20 0.41
TRPA1 O75762 2/20 0.40
AOC3 Q16853 1/20 0.39
CALM1 P0DP23 1/20 0.39
ADRA2B P18089 1/20 0.38
ADRA2C P18825 1/20 0.38
HTR2A P28223 1/20 0.38
ADRA1A P35348 1/20 0.38
OPRK1 P41145 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2867870 0.69 CALM1 (0.50) TAAR1CYP2A6TP53TRPA1CALM1
SCHEMBL11043268 0.67 TP53 (0.50) TAAR1SIGMAR1SLC6A2SLC6A4SLC6A3
Isobutylbenzene SCHEMBL2571645 0.65 SIGMAR1 (0.64) TAAR1SIGMAR1SLC6A2SLC6A4SLC6A3
SCHEMBL19066702 0.65 TAAR1 (0.56) TAAR1SIGMAR1SLC6A2SLC6A4SLC6A3
SCHEMBL11796645 0.65
SCHEMBL30934 0.65 TRPA1 (0.77) TAAR1SIGMAR1SLC6A2SLC6A4SLC6A3
SCHEMBL4785594 0.65 SIGMAR1 (0.64) TAAR1SIGMAR1SLC6A2SLC6A4SLC6A3
Hydrochloric Acid SCHEMBL5086819 0.65 TAAR1 (0.56) TAAR1SIGMAR1SLC6A2SLC6A4SLC6A3
Isobutylbenzene SCHEMBL7493657 0.65 SIGMAR1 (0.64) TAAR1SIGMAR1SLC6A2SLC6A4SLC6A3
Iodide SCHEMBL5086811 0.65 SIGMAR1 (0.56) TAAR1SIGMAR1SLC6A2SLC6A4SLC6A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0594291-A1 Novel processes for the production of 13-ether derivatives of milbemycins, and novel intermediates therefor SANKYO COMPANY LIMITED (JP) 1994-04-27 EP disclosed